Daniel Carestio Sells 3,054 Shares of STERIS (NYSE:STE) Stock

STERIS plc (NYSE:STE) CEO Daniel Carestio sold 3,054 shares of STERIS stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $214.64, for a total transaction of $655,510.56. Following the completion of the transaction, the chief executive officer owned 65,021 shares in the company, valued at $13,956,107.44. This trade represents a 4.49% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

STERIS Stock Performance

Shares of STE opened at $212.42 on Wednesday. The company has a market capitalization of $20.73 billion, a PE ratio of 26.79 and a beta of 0.93. STERIS plc has a one year low of $195.14 and a one year high of $269.44. The company has a debt-to-equity ratio of 0.25, a current ratio of 2.09 and a quick ratio of 1.54. The company’s fifty day moving average price is $216.83 and its 200 day moving average price is $238.33.

STERIS (NYSE:STE) last announced its earnings results on Monday, May 11th. The medical equipment provider reported $2.83 EPS for the quarter, missing the consensus estimate of $2.86 by ($0.03). STERIS had a return on equity of 14.15% and a net margin of 13.18%.The firm had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter last year, the business earned $2.74 EPS. The business’s revenue was up 6.7% compared to the same quarter last year. STERIS has set its FY 2027 guidance at 11.100-11.300 EPS. As a group, analysts expect that STERIS plc will post 11.18 earnings per share for the current year.

STERIS Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 26th. Stockholders of record on Monday, June 8th will be issued a dividend of $0.63 per share. The ex-dividend date is Monday, June 8th. This represents a $2.52 annualized dividend and a dividend yield of 1.2%. STERIS’s payout ratio is presently 31.78%.

Analyst Ratings Changes

Several research analysts have recently issued reports on the stock. KeyCorp dropped their price objective on shares of STERIS from $291.00 to $269.00 and set an “overweight” rating on the stock in a report on Wednesday, May 13th. Wall Street Zen downgraded shares of STERIS from a “strong-buy” rating to a “buy” rating in a report on Saturday. Weiss Ratings downgraded shares of STERIS from a “hold (c+)” rating to a “hold (c)” rating in a report on Wednesday, May 27th. Finally, Piper Sandler restated an “overweight” rating and set a $270.00 price objective on shares of STERIS in a report on Thursday, May 21st. Three research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $278.00.

Institutional Trading of STERIS

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Board of the Pension Protection Fund bought a new stake in STERIS in the fourth quarter valued at about $25,000. Activest Wealth Management increased its stake in STERIS by 423.8% in the fourth quarter. Activest Wealth Management now owns 110 shares of the medical equipment provider’s stock valued at $28,000 after acquiring an additional 89 shares during the period. Measured Wealth Private Client Group LLC bought a new stake in STERIS in the fourth quarter valued at about $28,000. Harbor Investment Advisory LLC increased its stake in STERIS by 115.4% in the fourth quarter. Harbor Investment Advisory LLC now owns 112 shares of the medical equipment provider’s stock valued at $28,000 after acquiring an additional 60 shares during the period. Finally, Western Wealth Management LLC bought a new stake in STERIS in the first quarter valued at about $25,000. Institutional investors own 94.69% of the company’s stock.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.